Patent ID: 9616019
Date: 2017-04-11
CPC Classifications: A61K,A61P,Y10S

Claim:
1. A stable, aqueous suspension having an enhanced bioavailability consisting of: particles of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide having a mean particle size of less than 800 nm, sodium lauryl sulfate (SLS) in a concentration of 0.2%, and hydropropylmethylcellulose (HPMC) in a concentration of 0.5%, wherein said suspension is suitable for long term storage; and wherein said suspension has a relative exposure that is 147% of the exposure of the suspension in the absence of SLS.